Memorial Sloan-Kettering Cancer Center

Your gift will enable Memorial Sloan-Kettering Cancer Center to continue to be on the forefront of research into new colorectal chemotherapy drugs. Memorial Sloan-Kettering helped establish the efficacy of irinotecan, the first new drug for colorectal cancer in 40 years. In some patients, irinotecan has been found to shrink metastatic tumors when other treatments have failed.

Your gift will support current research into new agents to treat lung cancer and prevent its recurrence. Memorial Sloan-Kettering researchers are evaluating new drugs for lung cancer, including getifinib (Iressa). First tested at MSKCC, getitinib is one of a new class of drugs known as signal transduction inhibitors, which work by blocking the signal that make cancer cells grow and spread.

Your gift will support the research of our physicians and scientists who continue to pioneer new medical treatments in breast cancer research such as immunotherapy, including vaccines and antibodies. Memorial Sloan-Kettering’s vaccine studies are designed to identify the best way to harness the body’s immune system to ward off recurrences. Our doctors have tested several monoclonal antibodies. They have so far demonstrated that this approach...

Today 10 million people in the U.S. are cancer survivors. In response to the increasing number of patients who are living beyond cancer, Memorial Sloan-Kettering Cancer Center has established the Cancer Survivorship Initiative to institute a comprehensive program of services for cancer survivors and their families and to develop a survivorship research effort that will address issues vital to survivors nationwide.

The Integrative Medicine Service at Memorial Sloan-Kettering Cancer Center was established in 1999 to complement mainstream medical care and address the emotional, social, and spiritual needs of patients and families. The Service includes inpatient and outpatient clinical care, research, and education and training. In addition, the Service provides unique access to otherwise unavailable information about over-the-counter products and unproven cancer treatments and their impact in...

Memorial Sloan-Kettering Cancer Center is one of only a few centers that offer computer-assisted family history analysis. Men with a family history of prostate cancer that suggests they may be at increased genetic risk for developing the disease can be referred to our genetic counselors who will help further evaluate their risks. Your gift will ensure that our researchers and physicians continue to make new...

Memorial Sloan-Kettering Cancer Center has a longstanding commitment to providing the best cancer care to everyone regardless of their ability to pay. Your gift will ensure MSKCC continues to make this vital assistance available to as many of our patients and their families as possible so that they may focus on their most important role—successfully undergoing cancer treatment.

Memorial Sloan-Kettering Cancer Center offers care that is unequaled in depth of experience and expertise in the treatment of cancer affecting children, teenagers, and young adults. The multidisciplinary approach at Memorial Sloan-Kettering offers children and young adults with cancer the best opportunity for accurate diagnosis and the most effective treatment available, emphasizing treatments that target and cure cancer and return children to a normal life....